MBRX · Moleculin Biotech, Inc. · Documents
$6.50
+0.61 (+10.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.33M
Shares
973,869
Volume · Oct 23
27.74K
Avg daily vol (4 sessions)
65.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-11-05 | — | |
| 8-K | — | 2024-10-25 | 2024-10-24 | |
| 8-K | — | 2024-10-17 | — | |
| 8-K | — | 2024-10-07 | — | |
| 8-K | — | 2024-10-02 | — | |
| 8-K | — | 2024-09-23 | — | |
| 8-K | — | 2024-09-16 | — | |
| 8-K | — | 2024-09-16 | — | |
| DEFA14A | — | 2024-09-13 | — | |
| DEF 14A | — | 2024-09-13 | 2024-10-24 | |
| 8-K | — | 2024-09-09 | — | |
| PRE 14A | — | 2024-09-03 | 2024-10-24 | |
| 8-K | — | 2024-08-19 | — | |
| 8-K | — | 2024-08-16 | 2024-08-15 | |
| S-1/A | — | 2024-08-15 | — | |
| S-1/A | — | 2024-08-15 | — | |
| 8-K | — | 2024-08-14 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-08-06 | — | |
| 8-K | — | 2024-08-05 | — | |
| 8-K | — | 2024-08-01 | — | |
| 8-K | — | 2024-08-01 | — | |
| S-1/A | — | 2024-07-30 | — | |
| S-1 | — | 2024-07-22 | — | |
| 8-K | — | 2024-07-10 | — | |
| 8-K | — | 2024-06-18 | — | |
| 8-K | — | 2024-06-14 | — | |
| S-3 | — | 2024-06-07 | — | |
| 8-K | — | 2024-05-16 | — | |
| 8-K | — | 2024-05-15 | — | |
| 8-K | — | 2024-05-14 | — | |
| 8-K | — | 2024-05-13 | — | |
| 8-K/A | — | 2024-05-13 | — | |
| 10-Q | — | 2024-05-10 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| 8-K | — | 2024-05-08 | — | |
| 8-K | — | 2024-05-07 | — | |
| 8-K | — | 2024-05-07 | — | |
| 8-K | — | 2024-05-02 | — | |
| 10-K/A | — | 2024-04-26 | 2023-12-31 | |
| 8-K | — | 2024-04-25 | — | |
| 8-K | — | 2024-04-18 | — | |
| 8-K | — | 2024-04-10 | — | |
| 8-K | — | 2024-04-08 | — | |
| 8-K | — | 2024-03-27 | — | |
| 8-K | — | 2024-03-25 | — | |
| 8-K | — | 2024-03-25 | — | |
| 8-K | — | 2024-03-22 | — | |
| 10-K | — | 2024-03-22 | 2023-12-31 | |
| 8-K | — | 2024-03-20 | — |
Showing 151–200 of 407 filings